References

1. Delatychi M, Rogers JG. The genetics of fibrodysplasia ossificans progressiva. ClinOrthopRel Res. 1998; 346: 15-18. PubMed | Google Scholar


2. Buyse G, Silberstein J, Goemans N, Casaer P. Fibrodysplasia ossificans progressiva: still turning into wood after 300 years? Eur J Pediatr. 1995; 154(9): 694-699. PubMed | Google Scholar


3. Rogers JG, GehoWB. Fibrodysplasia ossificans progressive: a survey of forty two cases. J Bone joint Surg. 1979; 61(6A): 909-14. PubMed | Google Scholar


4. Reinig JW, Hill SC, Fang M, Marini J, Zasloff MA. Fibrodyspla-siaOssificans Progressiva: CT Appearance. Radiology. 1986; 159(1): 153-7. PubMed | Google Scholar


5. Shafritz AB, Shore EM, Gannon FH. Overexpression of an osteogenicmorphogen in fibrodysplasia ossificans progressiva. N Engl J Med. 1996; 335(8): 555-561. PubMed | Google Scholar


6. Hiroaki H, Noriko A, Jiro M, Kazutoshi F, Shigeharu O, Gen N. Contrast-Enhanced MRI of an Early Preosseous Lesion of Fibrodysplasia Ossificans Progressiva in a 21-Month-Old Boy: Case report. AJR. October 2003; 181(4): 1145-1147. PubMed | Google Scholar


7. Elgazzar AH, Kriss VM, Gelfand MJ. Advanced fibrodysplasia ossificans progressiva. ClinNucl Med. 1995; 20(6): 519-521. PubMed | Google Scholar


8. Connor JM, Evans DA. Fibrodysplasia ossificans progressiva: the clinical features and natural history of 34 patients. J Bone Joint Surg. 1982; 64B(1):76-83. PubMed | Google Scholar


9. McEvoy GK. Unclassified therapeutic agents In: American Hospital Formulary Service (AHFS) Drug Information. Bethesda, Library of Congress. 2000; 3399-403. Google Scholar